Zhile Liu

430 total citations
14 papers, 322 citations indexed

About

Zhile Liu is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Zhile Liu has authored 14 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Epidemiology. Recurrent topics in Zhile Liu's work include Cancer-related molecular mechanisms research (4 papers), Curcumin's Biomedical Applications (2 papers) and MicroRNA in disease regulation (2 papers). Zhile Liu is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Curcumin's Biomedical Applications (2 papers) and MicroRNA in disease regulation (2 papers). Zhile Liu collaborates with scholars based in China and Russia. Zhile Liu's co-authors include Yanfang Zheng, Zhongjian Yu, Xiongjie Zhu, Lingyu Qin, Xiaoran Wu, Lian Deng, Longbao Feng, Rui Guo, Min Liang and Ying Li and has published in prestigious journals such as Carbohydrate Polymers, Cell Death and Disease and International Journal of Nanomedicine.

In The Last Decade

Zhile Liu

13 papers receiving 317 citations

Peers

Zhile Liu
Negar Azami Iran
Yonghong Guo China
Zhongjian Yu China
Vahideh Zarrin Iran
Yong Gao China
Nagma Banjare India
Xinkuang Liu China
Lulu Wang China
Mehri Ghasabi Iran
Haijun Lu China
Negar Azami Iran
Zhile Liu
Citations per year, relative to Zhile Liu Zhile Liu (= 1×) peers Negar Azami

Countries citing papers authored by Zhile Liu

Since Specialization
Citations

This map shows the geographic impact of Zhile Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhile Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhile Liu more than expected).

Fields of papers citing papers by Zhile Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhile Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhile Liu. The network helps show where Zhile Liu may publish in the future.

Co-authorship network of co-authors of Zhile Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhile Liu. A scholar is included among the top collaborators of Zhile Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhile Liu. Zhile Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Li, Rui, Zhile Liu, Wensou Huang, et al.. (2024). Microbial-derived Urolithin A Targets GLS1 to Inhibit Glutaminolysis and Attenuate Cirrhotic Portal Hypertension. Cellular and Molecular Gastroenterology and Hepatology. 18(4). 101379–101379. 2 indexed citations
2.
Liu, Zhile, Qi Wang, Yue Bi, et al.. (2023). Long non-coding RNA DINO promotes cisplatin sensitivity in lung adenocarcinoma via the p53-Bax axis. Journal of Thoracic Disease. 15(4). 2198–2212. 3 indexed citations
3.
Zhu, Xiongjie, Zhongjian Yu, Longbao Feng, et al.. (2021). Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer. Carbohydrate Polymers. 268. 118237–118237. 115 indexed citations
4.
Yu, Zhongjian, Xiongjie Zhu, Ying Li, et al.. (2021). Circ-HMGA2 (hsa_circ_0027446) promotes the metastasis and epithelial-mesenchymal transition of lung adenocarcinoma cells through the miR-1236-3p/ZEB1 axis. Cell Death and Disease. 12(4). 313–313. 31 indexed citations
5.
Zhu, Xiongjie, Ying Li, Lingyu Qin, et al.. (2021). Gemcitabine and Celecoxib Synergistically Promote Long-Lasting Antitumor Efficacy of Pd-1 Antibody by Triggering Immunogenic Cell Death. SSRN Electronic Journal. 1 indexed citations
6.
Deng, Lian, Xiaoran Wu, Xiongjie Zhu, et al.. (2021). Combination effect of curcumin with docetaxel on the PI3K/AKT/mTOR pathway to induce autophagy and apoptosis in esophageal squamous cell carcinoma.. American Journal of Translational Research. 13(1). 57–72. 25 indexed citations
7.
Deng, Lian, Xiongjie Zhu, Zhongjian Yu, et al.. (2020). <p>Novel T7-Modified pH-Responsive Targeted Nanosystem for Co-Delivery of Docetaxel and Curcumin in the Treatment of Esophageal Cancer</p>. International Journal of Nanomedicine. Volume 15. 7745–7762. 16 indexed citations
8.
He, Xin, Meng Fan, Zhongjian Yu, et al.. (2020). PLCD1 Suppressed Cellular Proliferation, Invasion, and Migration via Inhibition of Wnt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma. Digestive Diseases and Sciences. 66(2). 442–451. 10 indexed citations
9.
Wang, Qi, Zhile Liu, Kunpeng Du, et al.. (2019). Babaodan inhibits cell growth by inducing autophagy through the PI3K/AKT/mTOR pathway and enhances antitumor effects of cisplatin in NSCLC cells.. PubMed Central. 11(8). 5272–5283. 17 indexed citations
10.
He, Xin, Meng Fan, Lingyu Qin, et al.. (2019). KLK11 suppresses cellular proliferation via inhibition of Wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.. PubMed. 9(10). 2264–2277. 8 indexed citations
11.
Liang, Min, Guanqun Huang, Zhaoyu Liu, et al.. (2019). Elevated levels of hsa_circ_006100 in gastric cancer promote cell growth and metastasis via miR‐195/GPRC5A signalling. Cell Proliferation. 52(5). e12661–e12661. 67 indexed citations
12.
13.
Liu, Zhile, et al.. (2014). Case-Based Reasoning Algorithm Based on Qualitative Causality. 33. 519–523. 1 indexed citations
14.
Li, Fei, Xiao Huang, Tao Huang, et al.. (2013). The association of tea consumption with bladder cancer risk: a meta-analysis.. PubMed. 22(1). 128–37. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Negar Azami Breakdown of academic impact, for papers by Yonghong Guo Breakdown of academic impact, for papers by Zhongjian Yu Breakdown of academic impact, for papers by Vahideh Zarrin Breakdown of academic impact, for papers by Yong Gao Breakdown of academic impact, for papers by Nagma Banjare Breakdown of academic impact, for papers by Xinkuang Liu Breakdown of academic impact, for papers by Lulu Wang Breakdown of academic impact, for papers by Mehri Ghasabi Breakdown of academic impact, for papers by Haijun Lu
Rankless by CCL
2026